Company has no debt since last 5 years. (Source: Standalone Financials)
Elantas Beck India Share Price
Elantas Beck India Shar...
Elantas Beck share price insights
Company has spent less than 1% of its operating revenues towards interest expenses and 5.96% towards employee cost in the year ending Dec 31, 2023. (Source: Standalone Financials)
Stock gave a 3 year return of 229.95% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)
Stock generated 229.95% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Elantas Beck India Ltd. share price moved up by 1.65% from its previous close of Rs 12,000.00. Elantas Beck India Ltd. stock last traded price is 12,199.00
Share Price Value Today/Current/Last 12,199.00 Previous Day 12,000.00
Key Metrics
PE Ratio (x) | 64.23 | ||||||||||
EPS - TTM (₹) | 189.94 | ||||||||||
MCap (₹ Cr.) | 9,670.98 | ||||||||||
Sectoral MCap Rank | 41 | ||||||||||
PB Ratio (x) | 13.00 | ||||||||||
Div Yield (%) | 0.04 | ||||||||||
Face Value (₹) | 10.00 | ||||||||||
Beta Beta
| 0.42 | ||||||||||
VWAP (₹) | 12,051.65 | ||||||||||
52W H/L (₹) |
Elantas Beck Share Price Returns
1 Day | 1.65% |
1 Week | 1.81% |
1 Month | -3.72% |
3 Months | 3.15% |
1 Year | 73.24% |
3 Years | 229.95% |
5 Years | 470.98% |
Elantas Beck News & Analysis
NewsHunting multibaggers? D-Street experts swear by these themes
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
AnnouncementsCompliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
AnnouncementsCompliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcements
Elantas Beck Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Elantas Beck Financials
Income (P&L)
Balance Sheet
Cash Flow
Ratios
Insights
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 5.96% towards employee cost in the year ending Dec 31, 2023. (Source: Standalone Financials)
Quarterly | Annual Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 208.42 191.77 190.65 174.75 186.78 Total Income Growth (%) 8.68 0.58 9.10 -6.44 5.39 Total Expenses 155.91 142.13 141.34 127.97 139.22 Total Expenses Growth (%) 9.70 0.55 10.45 -8.08 1.84 EBIT 52.51 49.64 49.31 46.78 47.57 EBIT Growth (%) 5.78 0.67 5.41 -1.65 17.34 Profit after Tax (PAT) 41.85 36.91 37.00 34.83 35.42 PAT Growth (%) 13.38 -0.24 6.24 -1.68 17.86 EBIT Margin (%) 25.20 25.89 25.86 26.77 25.47 Net Profit Margin (%) 20.08 19.25 19.41 19.93 18.96 Basic EPS (₹) 52.79 46.56 46.67 43.93 44.68 All figures in Rs Cr, unless mentioned otherwise
Insights
Zero Debt Burden
Company has no debt since last 5 years. (Source: Standalone Financials)
Annual FY 2023 FY 2022 FY 2021 FY 2020 FY 2020 Total Assets 880.53 717.49 618.50 536.25 536.25 Total Assets Growth (%) 22.72 16.00 15.34 0.00 17.51 Total Liabilities 148.53 118.89 113.83 94.66 94.66 Total Liabilities Growth (%) 24.93 4.45 20.25 0.00 30.87 Total Equity 731.99 598.60 504.67 441.59 441.59 Total Equity Growth (%) 22.28 18.61 14.28 0.00 14.99 Current Ratio (x) 6.12 5.92 4.75 4.65 4.65 Total Debt to Equity (x) 0.00 0.00 0.00 0.00 0.00 Contingent Liabilities 13.25 6.32 8.92 56.90 56.90 All figures in Rs Cr, unless mentioned otherwise
Insights
Increase in Cash from Investing
Company has used Rs 131.53 cr for investing activities which is an YoY increase of 73.06%. (Source: Standalone Financials)
Annual FY 2023 FY 2022 FY 2021 FY 2020 FY 2020 Net Cash flow from Operating Activities 133.42 82.95 28.51 79.40 79.40 Net Cash used in Investing Activities -131.53 -76.00 -32.72 -69.11 -69.11 Net Cash flow from Financing Activities -4.52 -4.58 -4.21 -4.21 -4.21 Net Cash Flow -2.63 2.37 -8.43 6.08 6.08 Closing Cash & Cash Equivalent 3.23 5.86 3.49 11.92 11.92 Closing Cash & Cash Equivalent Growth (%) -44.93 67.85 -70.70 0.00 104.19 Total Debt/ CFO (x) 0.00 0.00 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2023 FY 2022 FY 2021 FY 2020 FY 2020 Return on Equity (%) 18.75 16.33 13.25 13.98 13.98 Return on Capital Employed (%) 24.34 19.24 15.79 17.63 17.63 Return on Assets (%) 15.59 13.62 10.81 11.51 11.51 Interest Coverage Ratio (x) 343.36 212.79 379.45 422.05 368.45 Asset Turnover Ratio (x) 0.85 0.97 0.90 0.77 71.44 Price to Earnings (x) 49.26 35.34 43.67 35.46 27.78 Price to Book (x) 9.20 5.76 5.77 4.95 3.88 EV/EBITDA (x) 34.05 25.91 30.61 23.42 18.30 EBITDA Margin (%) 28.84 20.38 18.11 24.04 24.04
Elantas Beck Peer Comparison
Elantas Beck Stock Performance
Ratio Performance
Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of 229.95% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 229.95% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Choose from Peers
Choose from Stocks
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Loading...Insights
Stock Returns vs Nifty Midcap 100
Stock gave a 3 year return of 229.95% as compared to Nifty Midcap 100 which gave a return of 112.53%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 229.95% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
See All Parameters
MF Ownership
765.02
Amount Invested (in Cr.)
1.27%
% of AUM
0.00
% Change (MoM basis)
268.57
Amount Invested (in Cr.)
3.18%
% of AUM
0.00
% Change (MoM basis)
127.65
Amount Invested (in Cr.)
1.53%
% of AUM
0.00
% Change (MoM basis)
MF Ownership as on 31 July 2024
Corporate Actions
Elantas Beck Board Meeting/AGM
Elantas Beck Dividends
- Others
Meeting Date Announced on Purpose Details Aug 06, 2024 Jul 24, 2024 Board Meeting Quarterly Results May 07, 2024 Apr 25, 2024 Board Meeting Quarterly Results Feb 20, 2024 Feb 02, 2024 Board Meeting Audited Results & Final Dividend Nov 07, 2023 Oct 25, 2023 Board Meeting Quarterly Results Aug 01, 2023 Jul 19, 2023 Board Meeting Quarterly Results Type Dividend Dividend per Share Ex-Dividend Date Announced on Final 50% 5.0 Apr 30, 2024 Feb 20, 2024 Final 50% 5.0 May 02, 2023 Feb 21, 2023 Final 50% 5.0 Apr 29, 2022 Feb 22, 2022 Final 50% 5.0 Apr 26, 2021 Feb 23, 2021 Final 50% 5.0 Jul 13, 2020 Feb 25, 2020 All Types Ex-Date Record Date Announced on Details Bonus Nov 18, 1991 Dec 16, 1991 Sep 30, 1991 Bonus Ratio: 1 share(s) for every 2 shares held Bonus - - Sep 26, 1988 Bonus Ratio: 1 share(s) for every 1 shares held Bonus - - Bonus Ratio: 4 share(s) for every 5 shares held
About Elantas Beck
Elantas Beck India Ltd., incorporated in the year 1956, is a Small Cap company (having a market cap of Rs 9,670.98 Crore) operating in Pharmaceuticals sector. Elantas Beck India Ltd. key Products/Revenue Segments include Wire Enamels & Impregnating Varnishes, Raw Materials and Scrap for the year ending 31-Dec-2023. Show More
Executives
Auditors
- MB
Martin Babilas
ChairmanSRSrikumar Ramakrishnan
Managing DirectorNDNandkumar Dhekne
DirectorRLRanjal Laxmana Shenoy
DirectorShow More - Price Waterhouse Chartered Accountants LLP
Industry
Key Indices Listed on
-
Address
147, Mumbai-Pune Road,Pimpri,Pune, Maharashtra - 411018
More Details
Trending in Markets
Elantas Beck Quick Links
Equity Quick Links
More from Markets
IPOStock market news
Budget 2022 Live Updates
Cryptocurrency
Currency converter
NSE holiday list
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.